MIXIF yields 3.20% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, MIXIF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MIXIF + JNJ for your $10,000?
mixi, Inc. engages in the entertainment and lifestyle businesses in Japan. It offers Monster Strike, Kotodaman, and Monster Strike Stadium gaming applications; TIPSTAR, a freemium online betting app; Chariloto, a keirin and auto race betting ticket sales site; Chiba Jets Funabashi; netkeiba.com, a national horse racing resource; and Weekly Baseball Online, a baseball information site. The company also provides FamilyAlbum, a family photo and video sharing app; minimo, a salon artist booking app; mixi, a social networking service that offers space for friendly communication; KARASTA, a karaoke video community; Find Job!, a job recruitment info site for the IT and web industries; and OKURU, a photo gift service. It also provides employment opportunities for people with disabilities; operates XFLAG stores that offer merchandise from game; organizes events; and produces and sells various goods, as well as manages professional sports team, and businesses related to publicly operated competitions and other services. Mixi Inc. offers social networking services that focuses on digital entertainment business, sports business, and lifestyle business. It allows users to connect with their friends. The company was formerly known as eMecury Co., Ltd. and changed its name to mixi, Inc. in February 2006. mixi, Inc. was founded in 1999 and is headquartered in Tokyo, Japan.
Full MIXIF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.